R/01
Legal Status Tracker
A maintained, cited, jurisdiction-by-jurisdiction record of possession, sale, prescription, import, and anti-doping status — with a change log and last-verified date on every entry.
Indexing
Monitoring SARMs research & development
The most comprehensive record of SARMs research in existence.
The headquarters for the studies, the clinical trials, the evidence, and the law governing selective androgen receptor modulators — monitored as they develop and catalogued in one continuously updated record.
The collective
“The single most comprehensive record of SARMs research in existence — one headquarters, continuously monitored.”
Compounds
14
Every notable selective androgen receptor modulator, tracked individually across science and law.
Jurisdictions
59
Legal status maintained across 50 US states and 9 national and sporting authorities.
Sources
Primary
Peer-reviewed literature, regulatory filings, and lab analyses, monitored as they publish.
Cadence
Continuous
The record is revised as trials report and the law changes, with every entry dated.
01
Three records at the core of the collective.
SARMs research is scattered across journals, trial registries, regulators, and forums. The Institute consolidates it. Three continuously maintained records form the spine of the collective.
R/02
Evidence Database
Per-compound entries grading the human, animal, and in-vitro evidence separately for efficacy and for harm — with study-level annotation and product-purity findings.
IndexingR/03
Clinical Trial Pipeline
An aggregated view of registered and published human trials, their phase, endpoints, and outcomes — so the actual state of the science is legible at a glance.
Indexing02
Legal status, stated precisely.
Most sources conflate “not scheduled,” “not approved for sale,” and “criminalised.” They are different things, and the difference is the point. A representative extract from the tracker follows.
EXTRACT · REPRESENTATIVE ROWS
LAST VERIFIED 2026‑07 · PRIMARY SOURCES CITED
| Jurisdiction | Possession | Sale for human use | Anti-doping | Controlling authority |
|---|---|---|---|---|
| United States Federal | Not scheduled | Unapproved drug | Prohibited | FDA: unapproved new drugs, not lawful in supplements or drugs. No SARMs Control Act enacted; not DEA-scheduled. |
| United Kingdom | Lawful | Prohibited | Prohibited | Human Medicines Regulations 2012 — sale/supply for human consumption unlawful; possession not criminalised. |
| Australia | Prescription only | Prescription only | Prohibited | TGA Schedule 4. Import/export without a permit carries criminal penalties. |
| Canada | Not criminalised | Not authorised | Prohibited | Health Canada — no authorised products; manufacture, advertising, sale, and import unlawful. |
| Sport WADA Code | — | — | Banned at all times | WADA Prohibited List, S1.2 — prohibited for all athletes in and out of competition. |
03
How we grade the evidence.
For most SARMs the human evidence is thin: a handful of early-phase trials, a large volume of animal work, and a growing case-report literature on harm. We grade efficacy and harm separately, and we make thinness visible rather than papering over it.
Certainty · High
Established
Supported by systematic review or replicated randomised human trials with clinical endpoints.
Certainty · Moderate
Probable
Backed by controlled human trials, often early-phase or on surrogate outcomes; further evidence may shift the estimate.
Certainty · Low
Preliminary
Signal from small or non-randomised human data, or strong animal evidence not yet confirmed in people.
Certainty · Very low
Insufficient
Mechanistic inference, in-vitro work, or isolated case reports. Not a basis for any claim of benefit.
A standing rule: harm signals are reported prominently even at low evidence grades. Absence of evidence is not evidence of safety. The Institute grades evidence — it does not issue recommendations to use.
04
Editorial standards.
The practices below are the ones health-information accreditation bodies assess. The Institute holds itself to them by default, not on request.
i
Primary sources, always
Every factual claim is cited to peer-reviewed literature, a regulator, or a statute. Legislative status is verified against the primary record before publication.
ii
Named authors and reviewers
Each page carries its author and its credentialed medical and legal reviewers, with linked biographies, credentials, and disclosures.
iii
Dated and re-reviewed
Content shows when it was last reviewed. Entries that fall out of date are visibly flagged rather than silently trusted.
iv
Corrections in the open
Errors are corrected promptly, the correction is noted on the page, and every change is kept in a public corrections log. Readers can report errors directly.
v
Fact separated from interpretation
What the evidence says and what we infer from it are visibly distinct. We do not publish dosing protocols or how-to-use guidance framed as recommendation.
vi
Continuously monitored
New trials, publications, and regulatory actions are logged as they appear, and existing entries are revised when the evidence moves.
This reference is for education and does not provide medical or legal advice. No SARM is approved for human use.